(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BREVAGENPLUS

This trademark appears in the official USPTO history.

Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILEDType: CombinedOffice: United States

Quick snapshot

BREVAGENPLUS

ST13

US500000079187611

Class

1, 5, 42, 44

Filing

79187611

Registration

5116659

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

Case type

Application and registration

Recorded events

29

Latest update

08/06/2026

Trademark type

Combined

Nice classes

1, 5, 42, 44

Filing date

01/15/2016

Registration date

01/10/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/15/2026

Last transaction

08/06/2026

Responsible office

United States Patent and Trademark Office

Status code

404

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

AU

Examiner

SEVERSON, JUSTIN

Law office

M20

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the term "BREVAGENPLUS" where the letters "BREVA" are black, the letters "GEN" are pink and the letters "PLUS." are teal. Above and to the left of the term is a pink rectangular design.

Holders and representatives

Holders

Genetic Technologies Limited

Representatives

Charles G. Zug Nelson Mullins Riley & Scarborough LLP

Technical classification

Nice Classes

Class 1Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Diagnostic preparations and reagents for scientific use; diagnostic preparations and reagents for scientific laboratory use; diagnostic test preparations comprised primarily of reagents and assays for scientific use

Class 5

Diagnostic preparations and reagents for clinical and medical use; diagnostic test preparations comprised primarily of reagents and assays for clinical and medical use

Class 42

Biotechnology research and development services for othersincluding genetic association studiesgenome mappinggenome analysis and genome scanningpharmaceutical drug and therapeutics development; product developmentincluding consumer health product development and consultation in the field of genomics and pharmaceutical drug development

Class 44

Medical diagnostic servicesincluding reagent sample testing and diagnostic services for others in the fields of science and medical research; genetic testing for medical purposesincluding genome mappinggenome analysisgenome scanning

Publications

History of USPTO decisions and trademark events.

29 publications found

DENA

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

08/06/2026

DETH

DEATH OF INTERNATIONAL REGISTRATION

08/06/2026

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

04/22/2024

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

04/03/2024

INPC

INVALIDATION PROCESSED

04/03/2024

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

03/21/2024

C71T

CANCELLED SECTION 71

07/21/2023

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

01/10/2022

FINV

FINAL DECISION TRANSACTION PROCESSED BY IB

04/29/2017

FICS

FINAL DISPOSITION NOTICE SENT TO IB

04/12/2017

FIMP

FINAL DISPOSITION PROCESSED

04/12/2017

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/10/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

01/10/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/25/2016

PUBO

PUBLISHED FOR OPPOSITION

10/25/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/05/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/13/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/12/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/12/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/12/2016

RFNT

REFUSAL PROCESSED BY IB

07/09/2016

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/22/2016

RFRR

REFUSAL PROCESSED BY MPU

06/22/2016

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/22/2016

CNRT

NON-FINAL ACTION WRITTEN

06/21/2016

MAFR

APPLICATION FILING RECEIPT MAILED

06/21/2016

DOCK

ASSIGNED TO EXAMINER

06/17/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/17/2016

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

06/16/2016

Continuous trademark protection

Get notified about every new filing that threatens BREVAGENPLUS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.